Pulmonary

An award-winning partner in Asthma and COPD, our market leading status is reinforced with proven innovations, development and analytical services and complete solutions – all designed to get your respiratory product to market faster and with less risk.

Aptar Pharma Delivery Routes

Unparalleled Expertise in Inhalation

Global leader in pulmonary drug delivery device solutions

Our pulmonary devices are considered the Gold Standard in the management and treatment of asthma and COPD.

Wide range of technology platforms

Our broad range of pMDI technology platforms, including metering valves, dose counters, Breath Activated Inhalers (BAIs) and Dry Powder inhalers (DPIs), are designed with the patient in mind, for the optimal treatment and management of asthma and COPD.

Improving patient outcomes

We offer a range of connected options to improve patient adherence, monitor their symptoms and improve patient health outcomes.

Leading the Way with Scientific Know-How and Development Support

Convenience, Reliability and Choice

We design, develop and manufacture a broad range of innovative and patient-focused respiratory drug delivery systems for optimal patient compliance. But we offer much more than a device – we provide complete drug delivery solutions.

Support at Every Stage of Your Development Journey

From your initial idea through formulation and development, clinical trials, analytical testing, and regulatory filings, we can add value at every stage of your drug development process.

Co-Organizer and Sponsor of RDD Europe

We strongly believe in advancing our scientific knowledge and expertise in respiratory conditions, and proudly co-organize RDD Europe, one of the largest respiratory drug delivery conferences worldwide, to share insights into issues facing the global inhalation community.

Services to Accelerate and Derisk Your Respiratory Project

Our analytical and regulatory services can help you better understand your APIs, drug substances and formulation challenges, as well as help guide you through the challenging and constantly evolving regulatory landscape.